cholestyramine resin has been researched along with nabumetone in 2 studies
| Studies (cholestyramine resin) | Trials (cholestyramine resin) | Recent Studies (post-2010) (cholestyramine resin) | Studies (nabumetone) | Trials (nabumetone) | Recent Studies (post-2010) (nabumetone) |
|---|---|---|---|---|---|
| 2,669 | 342 | 190 | 393 | 105 | 60 |
| Protein | Taxonomy | cholestyramine resin (IC50) | nabumetone (IC50) |
|---|---|---|---|
| Cytochrome P450 1A2 | Homo sapiens (human) | 5 | |
| Aldo-keto reductase family 1 member B1 | Rattus norvegicus (Norway rat) | 1.868 | |
| Amine oxidase [flavin-containing] A | Homo sapiens (human) | 0.998 | |
| Sodium-dependent noradrenaline transporter | Homo sapiens (human) | 1.868 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Brett, MA; Buscher, G; Ellrich, E; Greb, WH; Haddock, R; Kurth, HJ; Rülander, G; Schmerenbeck, B; Thawley, A | 1 |
| Brett, MA; Buscher, G; Ellrich, E; Greb, WH; Haddock, RE; Kurth, HJ; Rülander, G; Schmerenbeck, B; Thawley, AR | 1 |
1 trial(s) available for cholestyramine resin and nabumetone
| Article | Year |
|---|---|
Nabumetone. Evidence for the lack of enterohepatic circulation of the active metabolite 6-MNA in humans.
Topics: Adult; Anti-Inflammatory Agents, Non-Steroidal; Butanones; Cholestyramine Resin; Chromatography, High Pressure Liquid; Double-Blind Method; Enterohepatic Circulation; Half-Life; Humans; Male; Nabumetone; Naphthaleneacetic Acids | 1990 |
1 other study(ies) available for cholestyramine resin and nabumetone
| Article | Year |
|---|---|
Lack of enterohepatic circulation of the active metabolite of nabumetone in humans.
Topics: Adult; Anti-Inflammatory Agents, Non-Steroidal; Butanones; Cholestyramine Resin; Double-Blind Method; Enterohepatic Circulation; Humans; Male; Nabumetone; Naphthaleneacetic Acids; Osmolar Concentration; Placebos; Time Factors | 1992 |